tirzepatide medullary thyroid cancer GLP-1 Receptor Agonists and Risk, Rodent Data and FDA Warning, • In rodents, GLP-1 receptor agonists (GLP-1 RAs) stimulate thyroid C-cells, increasing the incidence of thyroid Frontiers | What is the

Other medications in this class, including Ozempic and Wegovy (semaglutide), show similar effects

Thyroid cancer may cause symptoms such as: swelling or a lump in your neck difficulty swallowing or breathing hoarseness that doesnt go away Your risk of thyroid cancer may be higher if: you or someone in your family has ever had a type of thyroid cancer called medullary thyroid cancer you have a condition called multiple endocrine neoplasia type 2, which raises your risk of thyroid cancer Due to the possible risk of thyroid cancer with Zepbound, your doctor likely will not prescribe this drug if these risk factors apply to you

2023, doi:10.1002/oby.23772 [5] Klausen et al., (2022) Exenatide once weekly for alcohol use disorder investigated in a randomized, placebo-controlled clinical trial

not a guarantee of medical outcomes

Side effects may include nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite, and indigestion

This integration is reliable for your website